...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Name Confusion

People bottom line do not trade either on Vancouver or OTC Us a.The company has stated that this has nothing to do with them.If we are listed then we will see about the Cusip.

Share
New Message
Please login to post a reply